Hyderabad, February 12 Biological E Limited announced on Thursday that the WHO has granted phase II pre-qualification for its Novel Oral Polio Vaccine type 2.Phase II pre-qualification covers both the drug substance and the drug product manufactured at BE, completing the full manufacturing...
biological e limited
circulating vaccine-derived poliovirus type 2 (cvdpv2)
novel oral polio vaccine type 2
polio vaccinevaccinemanufacturing
who pre-qualification